Sun Communities: The Stock That Sold Its Problems And Still Won't Stop Falling

Let's talk about Sun Communities (SUI), because the story they're telling and the story the tape is telling are two very different stories, and they don't end the same way.

Here's the official version. In September, Sun closed the sale of its UK business — Park Holidays and all — to Aermont Capital for net cash proceeds of USD 1.03 billion. Management calls it a repositioning: Sun is now a "leading North American pure-play MH and RV platform." They sliced the company down to something tidy: 455 developed properties, roughly 156,130 developed sites across the U.S. and Canada. It joined the S&P MidCap 400 in August, which means a fresh wave of passive money might show up. They granted themselves a new USD 1 billion buyback authority. There's a 3.66% dividend yield. This is supposed to be a cleaner, leaner, more strategic company than the one that existed a year ago.

Now here's the other version. The stock is sitting at USD 120.24, down roughly 3% year-to-date and down about 2.5% over the trailing year. It set new 52-week lows in September and October. Short interest jumped 23.54% month-over-month. On the day I'm writing this, it ticked up a hair, 0.32%, which is the kind of number that means absolutely nothing.

So which is it? A simplification story about to catch a bid, or a company whose market is quietly voting that the "cleaner" narrative doesn't cover the bill?

I'll take the tape.

The problem isn't the divestiture itself — selling the UK for what they got was arguably the right call, since the alternative was holding an asset through a valuation allowance that hit them for USD 1.10 billion in Q2. That single non-cash charge is what turned Sun's second-quarter GAAP result into a USD 992.70 million net loss and an EPS of –USD 8.08. Strip that out and the company actually generated USD 60.7 million in pro forma net income from continuing operations in the first half of 2026. Same-property real estate revenue rose 6.4%. The operating business, the part that isn't weighed down by dead European real estate, is fine. It's even decent.

But markets don't pay for "if you squint." They pay for the bottom line that shows up on the income statement, and Sun's keeps looking ugly. Fiscal 2026 consensus is a loss of USD 6.08 per share. Fiscal 2027 is expected to flip back positive at USD 3.35. And the upcoming Q3 print — due Tuesday, October 26, with the call the 27th — has consensus expecting EPS down 45.2% and revenue down 19.2% year-over-year. That's not a soft landing. That's a company mid-descent, telling you to hold for the recovery that isn't here yet.

And then there's the analyst camp, which has been cutting targets with a consistent, almost boring rhythm this October. Barclays trimmed USD 147 to 143. Wells Fargo to 136 from 141. UBS dropped all the way from 133 to 117 — that's not a trim, that's a re-rating. Morgan Stanley to 126. Every major desk with a number got it lower. The cluster now sits around USD 136 to 137, versus BofA's USD 140 target floating around. The desk data I'm looking at puts the consensus target at USD 135.76, implying maybe 13% "upside" from USD 120 — if you believe the targets, which a lot of these same banks just slashed.

Here's what I actually find interesting about this setup, and it's the reason I'm not just writing it off. Sun is buying back its own stock aggressively — 3.5 million shares for USD 425 million through late September — into a market that keeps making it cheaper. That's capital allocation with a spine when the price is right, and it's a problem for sellers, not buyers, if the earnings ever stop hemorrhaging. The dividend's been growing for eight years. The balance sheet isn't broken (Debt/Equity 0.73). The core business is producing.

The thing standing between this stock and a real re-rating is Tuesday. Q3 will tell you whether the UK wind-down is a one-time book cost or whether the operating numbers are actually deteriorating — that –19.2% revenue expectation is the number that keeps me up. If revenue holds and it's just the accounting ghost of the UK deal still haunting the tape, Sun at USD 120 with a 13% target premium and a company buying its own shares looks like a live, if fragile, value setup. If revenue keeps sliding, the "pure-play" story is just a prettier way to describe a slower bleed.

My read? This isn't a sell-the-news-from-above story and it isn't a slam dunk buy either. It's a see-what-happens-on-Tuesday story. The business is fine. The balance sheet is intact. The market just hasn't stopped discounting the UK wound-down as if there's more to come, and until Q3 proves otherwise, I'm letting the earnings do the talking.

Buy the simplification if the numbers back it up Tuesday. Keep your powder dry if they don't. The stock has already told you where it thinks it's worth — it's just quietly walking to new lows while management gives you a cleaner slide deck. In my experience, you trust the price, not the deck.